| (19) |
 |
|
(11) |
EP 1 595 955 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
published in accordance with Art. 158(3) EPC |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
26.04.2006 Bulletin 2006/17 |
| (43) |
Date of publication: |
|
16.11.2005 Bulletin 2005/46 |
| (22) |
Date of filing: 23.01.2004 |
|
| (51) |
International Patent Classification (IPC):
|
| (86) |
International application number: |
|
PCT/JP2004/000608 |
| (87) |
International publication number: |
|
WO 2004/065605 (05.08.2004 Gazette 2004/32) |
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
| (30) |
Priority: |
23.01.2003 JP 2003014792
01.08.2003 JP 2003285310
21.11.2003 JP 2003392555
|
| (71) |
Applicant: National Institute of Advanced Industrial Science
and Technology |
|
Tokyo 100-8921 (JP) |
|
| (72) |
Inventors: |
|
- NARIMATSU, Hisashi
Tsubuka-shi,
Ibaraki 3058568 (JP)
- TOGAYACHI, Akira
Tsubuka-shi,
Ibaraki 3058568 (JP)
- INABA, Niro
Hachioji-shi, Tokyo 1920031 (JP)
- HIRUMA, Toru
Tsubuka-shi,
Ibaraki 3058568 (JP)
- ISHIZUKA, Yasuko
Tsubuka-shi,
Ibaraki 3058568 (JP)
|
| (74) |
Representative: HOFFMANN EITLE |
|
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München
81925 München (DE) |
|
| |
|
| (54) |
BETA 1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME
AND METHOD OF EXAMINING CANCERATION USING THE SAME |
(57) The N-acetyl-D-galactosamine transferase protein of the present invention is
characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage,
and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration
assay according to the present invention uses a nucleic acid for measurement which
hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO:
1 or 3 or a nucleotide sequence complementary to at least one of them.